Details

Autor(en) / Beteiligte

• Tam, Otto C. H
• Ho, Ronnie S. L
• Chan, Shing
• Li, Kay K. W
• Lam, Tit-Leung
• Cheung, Elaine T. Y
• Cheung, Oi-Yee
• Ho, Wilson W. S
• Cheng, Kevin K. F
• Shing, Matthew M. K
• Ku, Dennis T. L
• Chung, Brian H. Y
• Yang, Wanling
• Chan, Godfrey C. F
• Ng, Ho-Keung
• Liu, Anthony P. Y

Titel

Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong

Ist Teil von

• Cancers, 2023-10, Vol.15 (19), p.4880

Ort / Verlag

Basel: MDPI AG

Erscheinungsjahr

2023

Link zum Volltext

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• This paper examines the link between CNS tumor biology and heterogeneity and the use of genome-wide DNA methylation profiling as a clinical diagnostic platform. CNS tumors are the most common solid tumors in children, and their prognosis remains poor. This study retrospectively analyzed pediatric patients with CNS embryonal tumors in Hong Kong between 1999 and 2017, using data from the territory-wide registry and available formalin-fixed paraffin-embedded tumor tissue. After processing archival tumor tissue via DNA extraction, quantification, and methylation profiling, the data were analyzed by using the web-based DKFZ classifier (Molecular Neuropathology (MNP) 2.0 v11b4) and t-SNE analysis. Methylation profiles were deemed informative in 85 samples. Epigenetic data allowed molecular subgrouping and confirmed diagnosis in 65 samples, verified histologic diagnosis in 8, and suggested an alternative diagnosis in 12. This study demonstrates the potential of DNA methylation profiling in characterizing pediatric CNS embryonal tumors in a large cohort from Hong Kong, which should enable regional and international collaboration in future pediatric neuro-oncology research.